Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Starting soon · Phase 1

Conditions studied: Gastric Adenocarcinoma

In brief

This phase I finds out the possible benefits and/or side effects of using magnetic tracer FerroTrace and the fluorescent dye indocyanine green to identify the lymph nodes that cancer is most likely to have spread to in patients with gastric cancer that are undergoing gastrectomy. Using FerroTrace in combination with the indocyanine green dye may help researchers better detect the disease.

Key facts

Study ID

NCT05038098

Run by

M.D. Anderson Cancer Center

People needed

20

Starts

2026-03-31

Expected to finish

2027-02-02

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or older
• Willing to provide informed consent
• Biopsy proven gastric cancer, undergoing curative-intent gastrectomy
• No distant metastases
• Pathologic diagnosis of gastric adenocarcinoma
• Pre-treatment endoscopic measurement of less than or equal to 4 cm in diameter of the gastric cancer

You may not qualify if…

• Contraindications to surgery +/- adjuvant therapy
• Allergy or intolerance to iron oxide compounds
• Allergy or intolerance to iodides
• Iron overload disorder
• Pregnant or lactating women*
• Use of contraception is required for females during the study. Male patients who are sexually active with a female of childbearing potential are allowed for study enrollment and will not require use of contraception

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.